NO20074854L - Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel - Google Patents

Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel

Info

Publication number
NO20074854L
NO20074854L NO20074854A NO20074854A NO20074854L NO 20074854 L NO20074854 L NO 20074854L NO 20074854 A NO20074854 A NO 20074854A NO 20074854 A NO20074854 A NO 20074854A NO 20074854 L NO20074854 L NO 20074854L
Authority
NO
Norway
Prior art keywords
sequestering agent
compressed
aerosol formulations
dose inhalers
pharmaceutical aerosol
Prior art date
Application number
NO20074854A
Other languages
English (en)
Inventor
Maurizio Delcanale
David Lewis
Brian John Meakin
Fausto Pivetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36490097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074854(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20074854L publication Critical patent/NO20074854L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

Aerosoloppløsningsformulering for bruk i en aerosolinhalator som omfatter minst én aktiv bestanddel valgt fira gmppen bestående av 20-ketosteroider og kinolinonderivater, et drivmiddel inneholdende et hydrofiuoralkan, og et koløsningsmiddel, stabilisert ved tilsetning av en spesifikk mengde av et sekvestreringsmiddel.
NO20074854A 2005-02-25 2007-09-24 Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel NO20074854L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05004233 2005-02-25
PCT/EP2006/001287 WO2006089656A2 (en) 2005-02-25 2006-02-13 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Publications (1)

Publication Number Publication Date
NO20074854L true NO20074854L (no) 2007-09-24

Family

ID=36490097

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074854A NO20074854L (no) 2005-02-25 2007-09-24 Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel

Country Status (23)

Country Link
US (1) US8877164B2 (no)
EP (1) EP1850831B1 (no)
JP (1) JP5259193B2 (no)
KR (1) KR101313959B1 (no)
CN (1) CN101119706B (no)
AR (2) AR054230A1 (no)
AU (1) AU2006218177B2 (no)
BR (1) BRPI0607990A2 (no)
CA (1) CA2594127C (no)
EA (1) EA013405B1 (no)
GE (1) GEP20105040B (no)
HK (1) HK1116337A1 (no)
IL (1) IL184449A0 (no)
MA (1) MA29333B1 (no)
MX (1) MX2007010396A (no)
NO (1) NO20074854L (no)
NZ (1) NZ556376A (no)
PE (1) PE20061011A1 (no)
SG (1) SG159550A1 (no)
TN (1) TNSN07289A1 (no)
UA (1) UA92732C2 (no)
WO (1) WO2006089656A2 (no)
ZA (1) ZA200706870B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112902A2 (en) * 2004-05-13 2005-12-01 Chiesi Farmaceutici S.P.A. Medicinal aerosol formulation products with improved chemical stability
GB201200525D0 (en) * 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
RU2519653C1 (ru) * 2013-02-27 2014-06-20 Шолекс Девелопмент Гмбх, Аэрозольный препарат на основе ипратропия бромида для лечения заболеваний органов дыхания
US10034866B2 (en) * 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US11642372B2 (en) 2020-05-01 2023-05-09 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US12042514B2 (en) 2020-05-01 2024-07-23 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US11826382B2 (en) 2020-05-01 2023-11-28 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA939195B (en) * 1992-12-09 1995-06-08 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
DK0735884T3 (da) 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
EP0843548A4 (en) * 1995-06-07 1998-10-28 Rhone Poulenc Rorer Pharma STABILIZED STEROID COMPOSITIONS
WO1997001329A1 (de) * 1995-06-27 1997-01-16 Boehringer Ingelheim Kg Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
WO2001087203A1 (en) * 2000-05-17 2001-11-22 Chrysalis Technologies Incorporated Stabilized budesonide solution and method for making same
DZ3358A1 (fr) * 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
ES2745064T3 (es) * 2002-03-01 2020-02-27 Chiesi Farm Spa Formulación superfina de formoterol
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
AU2003232201B2 (en) 2002-04-12 2009-06-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments containing betamimetic drugs and a novel anticholinesterase drug
DE10230769A1 (de) 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
AU2003291634A1 (en) * 2002-10-08 2004-05-04 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
ZA200706870B (en) 2008-11-26
US8877164B2 (en) 2014-11-04
WO2006089656A2 (en) 2006-08-31
UA92732C2 (ru) 2010-12-10
MA29333B1 (fr) 2008-03-03
AU2006218177B2 (en) 2012-04-12
EA013405B1 (ru) 2010-04-30
CA2594127C (en) 2013-10-15
CA2594127A1 (en) 2006-08-31
KR20070107002A (ko) 2007-11-06
MX2007010396A (es) 2007-10-19
US20060193785A1 (en) 2006-08-31
EP1850831A2 (en) 2007-11-07
PE20061011A1 (es) 2006-12-08
AR099963A2 (es) 2016-08-31
GEP20105040B (en) 2010-07-12
CN101119706B (zh) 2013-04-17
TNSN07289A1 (en) 2008-12-31
EA200701805A1 (ru) 2008-02-28
WO2006089656A3 (en) 2006-12-21
CN101119706A (zh) 2008-02-06
HK1116337A1 (en) 2008-12-19
AR054230A1 (es) 2007-06-13
IL184449A0 (en) 2007-10-31
JP5259193B2 (ja) 2013-08-07
SG159550A1 (en) 2010-03-30
JP2008537729A (ja) 2008-09-25
BRPI0607990A2 (pt) 2009-10-27
KR101313959B1 (ko) 2013-10-02
EP1850831B1 (en) 2015-12-02
AU2006218177A1 (en) 2006-08-31
NZ556376A (en) 2010-01-29

Similar Documents

Publication Publication Date Title
NO20074854L (no) Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
AR059350A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
WO2007123945A3 (en) Mechanical single dose intrapulmonary drug delivery devices
DE60308997D1 (de) Formulierungen zur inhalation
AR057745A1 (es) Formulaciones de disoluciones de hfc que contienen hidrocloruro de salbutamol o citrato de salbutamol
UY29905A1 (es) Formulación farmacéutica de absorción oral y su método de administración
RS52940B (en) PHARMACEUTICAL FORMULATIONS OF SOLUTION FOR MEASURED DOSES OF PRESSURE INHALATORS
AR019690A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
WO2007095043A3 (en) Pharmaceutical formulations
DK1883400T3 (da) Kapsler til inhalatorer
BRPI0507225A2 (pt) formulações estáveis de solução farmacêutica para inaladores pressurizados de dose medida
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
DE60031504D1 (de) Fluticasonpropionat arzneizubereitung
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
BR0107730A (pt) Inalador aerosol
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
CL2012000947A1 (es) Formulación en suspensión para inhalar de dosis medida que comprende fumarato de formoterol dihidratado y propionato de fluticasona y microlin sodico en un propelente hfa; composicion farmaceutica; un producto; uso de 0,01 a 0,1% cromolin sodico, util en asma y rinitis.
NO20062279L (no) Farmasoytiske preparater
HK1103280A1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ZA200606577B (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
AU2003215588A1 (en) Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
UA90346C2 (ru) Фармацевтическая рецептура для перорального приема и способ введения пациенту
TH104260B (th) สูตรผสมยาละอองฝอย สำหรับยาสูดของเบต้าอะโกนิสต์

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application